27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Ron Erickson, Chairman and CEO of Know Labs, Inc (NYSEAMERICAN: KNW) was recently a guest on Benzinga’s All-Access.
Know Labs is a medical technology company that develops non-invasive medical diagnostics. Its proprietary technology platform, Bio-RFID, uses electromagnetic energy in the form of radio waves to non-invasively capture molecular signatures which can be converted into physiologically meaningful information and insights.
While the technology platform can measure a range of different analytes both inside and outside the body, the company is focused on the non-invasive measurement of blood glucose. It reports that there are over 1.5 billion people around the world living with diabetes and pre-diabetes. Currently, there are no medical-grade commercially available, truly non-invasive means of measuring blood glucose levels.
Watch the full interview here:
Featured photo by National Cancer Institute on Unsplash.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!